Previous 10 | Next 10 |
2023-08-29 16:02:05 ET Catalent, Inc. (CTLT) Q4 2023 Earnings Conference Call August 29 2023, 8:15 AM ET Company Participants Paul Surdez - Vice President, Investor Relations John Greisch - Executive Chair, Board Alessandro Maselli - President and CEO Matti M...
2023-08-29 07:50:39 ET Catalent ( NYSE: CTLT ) said it entered into a cooperation agreement with activist investor Elliott Investment Management and will add four new directors, expanding its board to 16 members. Catalent rose 3.4% in premarket trading. The contract drug mak...
Adding Four New Independent Directors Appoints John Greisch as Executive Chair Establishes New Strategic and Operational Review Committee of the Board Enters into Cooperation Agreement with Elliott Investment Management L.P. Catalent, Inc. (NYSE: CTLT), the leade...
2023-08-29 07:04:51 ET More on Catalent Catalent: Myriad Issues To Fix Catalent nears settlement with activist Elliott for board seats - report Novo Nordisk chief 'confident' Catalent Wegovy issues will be fixed - report Catalent accused of misleading investo...
Q4'23 net revenue of $1.07 billion decreased (17)% as reported, or (17)% in constant currency, compared to Q4'22. Organic, constant-currency net revenue decreased (19)%, compared to Q4'22. Fiscal 2023 net revenue of $4.28 billion decreased (11)% as reported, or (9)% in constant cu...
2023-08-28 17:19:37 ET More on Catalent Catalent: Myriad Issues To Fix N ovo Nordisk chief 'confident' Catalent Wegovy issues will be fixed - report Catalent accused of misleading investors in shareholder suit Corvex Management adds Catalent, exits California...
2023-08-28 12:25:03 ET More on Catalent Catalent: Myriad Issues To Fix Catalent, Inc. 2023 Q3 - Results - Earnings Call Presentation Catalent, Inc. ( CTLT ) Q3 2023 Earnings Call Transcript Novo Nordisk chief 'confident' Catalent Wegovy issues will be fix...
2023-08-24 13:24:45 ET Summary This article discusses Mr. Loeb's 13F portfolio, which we have not been previously covered. The fund's largest ownership stake is now in Bath and Body Works. The famed investor is now heavily invested in the tech sector and made substantial sales...
2023-08-23 09:00:14 ET More on Novo, Thermo, etc. Thermo Fisher: Cash Flow Returns On Investments Analysis Novo Nordisk A/S 2023 Q2 - Results - Earnings Call Presentation Novo Nordisk A/S ( NVO ) Q2 2023 Earnings Call Transcript Novo Nordisk: Market Leade...
Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced that it will release financial results for the fourth quarter of fiscal year 2023 ended June 30, 2023, before the market open on Tuesday, August 29, 2023. Th...
News, Short Squeeze, Breakout and More Instantly...
Expansion adds more temperature-controlled storage and dedicated space for FastChain ® demand-led supply service Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced it has completed expansio...
2024-06-30 17:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-28 07:15:04 ET Barclays analyst issues EQUAL-WEIGHT recommendation for CTLT on June 28, 2024 05:28AM ET. The previous analyst recommendation was Equal-Weight. CTLT was trading at $56.41 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...